Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES SUVEN LIFE SCIENCES INDOCO REMEDIES/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 30.0 -20.5 - View Chart
P/BV x 2.9 5.8 50.9% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 INDOCO REMEDIES   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-23
SUVEN LIFE SCIENCES
Mar-23
INDOCO REMEDIES/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs42394 451.3%   
Low Rs30845 684.2%   
Sales per share (Unadj.) Rs181.10.6 29,165.5%  
Earnings per share (Unadj.) Rs15.4-5.4 -284.6%  
Cash flow per share (Unadj.) Rs23.1-5.1 -450.9%  
Dividends per share (Unadj.) Rs2.250-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs111.517.2 647.9%  
Shares outstanding (eoy) m92.15218.07 42.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.0111.8 1.8%   
Avg P/E ratio x23.7-12.8 -185.1%  
P/CF ratio (eoy) x15.8-13.5 -116.8%  
Price / Book Value ratio x3.34.0 81.3%  
Dividend payout %14.60-   
Avg Mkt Cap Rs m33,68315,131 222.6%   
No. of employees `000NANA-   
Total wages/salary Rs m3,226186 1,732.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m16,686135 12,324.5%  
Other income Rs m2484 28.2%   
Total revenues Rs m16,710220 7,599.6%   
Gross profit Rs m2,860-1,196 -239.1%  
Depreciation Rs m70665 1,079.1%   
Interest Rs m2505 4,652.2%   
Profit before tax Rs m1,928-1,183 -163.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5050-   
Profit after tax Rs m1,423-1,183 -120.3%  
Gross profit margin %17.1-883.6 -1.9%  
Effective tax rate %26.20-   
Net profit margin %8.5-873.5 -1.0%  
BALANCE SHEET DATA
Current assets Rs m8,0823,455 233.9%   
Current liabilities Rs m4,2451,050 404.2%   
Net working cap to sales %23.01,776.0 1.3%  
Current ratio x1.93.3 57.9%  
Inventory Days Days253,948 0.6%  
Debtors Days Days768218 352.7%  
Net fixed assets Rs m9,0551,373 659.4%   
Share capital Rs m184218 84.5%   
"Free" reserves Rs m10,0923,535 285.5%   
Net worth Rs m10,2763,753 273.8%   
Long term debt Rs m1,4350-   
Total assets Rs m17,1374,828 354.9%  
Interest coverage x8.7-218.8 -4.0%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.00 3,472.2%   
Return on assets %9.8-24.4 -40.0%  
Return on equity %13.8-31.5 -43.9%  
Return on capital %18.6-31.4 -59.3%  
Exports to sales %47.540.4 117.3%   
Imports to sales %11.5839.8 1.4%   
Exports (fob) Rs m7,91955 14,463.6%   
Imports (cif) Rs m1,9171,137 168.6%   
Fx inflow Rs m7,91955 14,463.6%   
Fx outflow Rs m1,9171,137 168.6%   
Net fx Rs m6,002-1,082 -554.5%   
CASH FLOW
From Operations Rs m1,788-1,031 -173.4%  
From Investments Rs m-2,082-2,606 79.9%  
From Financial Activity Rs m2283,955 5.8%  
Net Cashflow Rs m-65317 -20.6%  

Share Holding

Indian Promoters % 58.7 69.6 84.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 21.3 0.6 3,863.6%  
FIIs % 1.7 0.5 313.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 41.3 30.4 135.6%  
Shareholders   32,600 74,003 44.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Indoco Remedies vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Indoco Remedies vs Suven Life Sciences Share Price Performance

Period Indoco Remedies Suven Life Sciences S&P BSE HEALTHCARE
1-Day -1.81% 0.30% 1.18%
1-Month -6.44% -2.06% -0.75%
1-Year 1.11% 114.92% 61.82%
3-Year CAGR 4.71% 14.94% 18.16%
5-Year CAGR 11.97% -16.22% 19.79%

* Compound Annual Growth Rate

Here are more details on the Indoco Remedies share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of Indoco Remedies hold a 58.7% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Indoco Remedies and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, Indoco Remedies paid a dividend of Rs 2.3 per share. This amounted to a Dividend Payout ratio of 14.6%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Indoco Remedies, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.